Susan Prohaska is the founder of Jasper Therapeutics. Jasper Therapeutics has raised $35M in total funding. Latest round: Series A.
Susan Prohaska is a Stanford University-trained immunologist, stem cell biologist, and early-stage drug development professional. She co-founded Jasper Therapeutics, a clinical-stage biotechnology company, in March 2018 with Judith Shizuru. The company focuses on developing conditioning agents and therapies for hematopoietic stem cell transplants and gene therapies.
Full founder directory · Investor directory · Company funding database · Fundraising library